Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Diiodohydroxyquinoline, also known as uidoquinol and iodoquinol, is a quinoline derivative that can be used in the treatment of amoebiasis. The exact mechanism of action is unknown. Iodoquinol is not... Iodoquinol is not currently available in any FDA-approved products.
- Mechanism
- Curator reviewed
Unknown.
- Primary indication
- Used in the treatment of amoebiasis.Curator reviewed · 7 structured indications
- Formula / weight
- C9H5I2NO · 396.954 g/mol (avg)
- First approval
- Canada, 1963
- Also known as
- Diiodohydroxyquin · Iodoquinol · Ioquin
- Code names
- NSC-8704 · SS-578
- Brand names
- Alcortin
- Alcortin A
- Aloquin
- Dermazene
- Vytone
Resolves to
Clinical / RWD
Structure
InChIKey
UXZFQZANDVDGMM-UHFFFAOYSA-NSMILESOC1=C2N=CC=CC2=C(I)C=C1IWhat you can answer from here — as of August 16, 2026
Which other approved drugs treat the same conditions as Diiodohydroxyquinoline, and which companies have late-stage candidates in those indications?